fibrinolytic TAFIa carboxypeptidase inhibitor
Ph. II candidate for pulm. embolism; discont.
from literature pharmacophore and SBDD
J. Med. Chem., Mar. 25, 2021
Servier, Croissy-sur-Seine, FR
The Servier thrombin activatable fibrinolysis inhibitor (TAFIa) inhibitor (S62798) is a fibrinolytic (clot degrading) agent which entered Ph. II in the EU for pulmonary embolism, but development appears to have been…